Patent · US Active

Materials and methods for the generation of transcripts comprising modified nucleotides

US8101385B2 · kind B2 · utility

63Cited by
39References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2007
Grant dateJan 24, 2012
Priority date—
Expiry dateJan 3, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P19/34
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Materials and methods are provided for producing aptamer therapeutics having modified nucleotide triphosphates incorporated into their sequence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.